CCCR Stock Recent News China Commercial Credit Inc (CCCR) 2.98

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 1:52 PM

China Commercial Credit Inc (CCCR) 2.98 $CCCR

China Commercial Credit Completes First Two Equipment Leasing Agreements
ACCESSWIRE - Thu Oct 30, 7:02AM CDT
WUJIANG, CHINA / ACCESSWIRE / October 30, 2014 / China Commercial Credit, Inc. (NASDAQCM: CCCR), a microfinance company in Jiangsu Province, today announced that its wholly-owned subsidiary, Pride Financial Leasing (Suzhon) Co. Ltd., had executed its first two agreements to lease equipment to commercial entities.
CCCR: 2.98 (-0.02)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against China Commercial Credit, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 6, 2014
Business Wire - Thu Oct 02, 5:06PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased China Commercial Credit, Inc. ("China Commercial" or the "Company"

(NasdaqCM:CCCR) common stock between November 14, 2013 and July 25, 2014.
CCCR: 2.98 (-0.02)

EQUITY ALERT: Rosen Law Firm Reminds China Commercial Credit, Inc. Investors of Important October 6, 2014 Class Action Deadline -- CCCR
GlobeNewswire - Fri Sep 26, 5:46PM CDT
The Rosen Law Firm, P.A. reminds purchasers of China Commercial Credit, Inc. securities ("CCCR", or the "Company"

(Nasdaq:CCCR) between November 14, 2013 and July 25, 2014, of the important October 6, 2014 lead plaintiff deadline in the class action filed by the firm.
CCCR: 2.98 (-0.02)

China Commercial Credit Comments on Trading Halt
eTeligis - Fri Sep 19, 7:01AM CDT
WUJIANG, China, via ETELIGIS INC., 09/19/2014 - - China Commercial Credit, Inc. (NASDAQ: CCCR), a microfinance company in Jiangsu Province, today responded to inquiries by shareholders regarding the recent halting of trading in the company's NASDAQ-listed shares.
CCCR: 2.98 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against China Commercial Credit, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 6, 2014 -- CCCR
GlobeNewswire - Mon Sep 15, 2:58PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased China Commercial Credit, Inc. ("China Commercial" or the "Company"

(Nasdaq:CCCR) common stock between November 14, 2013 and July 25, 2014.
CCCR: 2.98 (-0.02)

NASDAQ Halts China Commercial Credit Inc.
GlobeNewswire - Thu Sep 11, 2:46PM CDT
The NASDAQ Stock Market (Nasdaq:NDAQ) announced that trading was halted today in China Commercial Credit Inc. (Nasdaq:CCCR) at 14:56:06 Eastern Time for "additional information requested" from the company at a last price of $ 2.9801.
CCCR: 2.98 (-0.02), NDAQ: 43.88 (-0.02)

China Commercial Credit Receives Nasdaq Notice on Late Filing of Second Quarter 10-Q
Marketwire - Thu Sep 04, 7:01AM CDT
China Commercial Credit, Inc. (NASDAQ: CCCR), a microfinance company providing financial services to small-to-medium enterprises (SMEs), farmers and individuals in Jiangsu Province, today said it has received a Notice from the Nasdaq Stock Market notifying the company that, due to its Form 10-Q for the second quarter ended June 30, 2014 (the "Q2 10-Q"

not being filed with the Securities and Exchange Commission by the required date of August 15, 2014, the company is therefore not in compliance with the periodic filing requirements for continued listing set forth in NASDAQ Listing Rule 5250(c)(1).
CCCR: 2.98 (-0.02)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving China Commercial Credit, Inc. and a Lead Plaintiff Deadline of October 6, 2014
GlobeNewswire - Wed Aug 27, 3:52PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased China Commercial Credit, Inc. ("China Commercial" or the "Company"

(Nasdaq:CCCR) common stock between November 14, 2013 and July 25, 2014.
CCCR: 2.98 (-0.02)

EQUITY ALERT: Rosen Law Firm Reminds China Commercial Credit, Inc. Investors of Important Class Action Deadline -- CCCR
GlobeNewswire - Mon Aug 25, 12:02PM CDT
The Rosen Law Firm, P.A. reminds purchasers of China Commercial Credit, Inc. securities (Nasdaq:CCCR) between November 14, 2013 and July 25, 2014, including those purchasers in the Company's public offering on or after May 7, 2014, of the important October 6, 2014 lead plaintiff deadline in the class action filed by the firm.
CCCR: 2.98 (-0.02)

China Commercial Credit Announces Management Changes
Marketwire - Mon Aug 25, 7:15AM CDT
The board of directors of China Commercial Credit, Inc. (NASDAQ: CCCR), a microfinance company providing financial services to small-to-medium enterprises (SMEs), farmers and individuals in Jiangsu Province, today said it had accepted the resignation of Mr. Huichun Qin as CCC's chairman and chief executive officer. Mr. Qin also relinquished his position as CEO and general manager of CCC's operating company, Wujiang Luxiang Microcredit Co. Ltd., and as CEO of CCC's wholly-owned equipment leasing subsidiary, Pride Financial Leasing Co. Ltd.
CCCR: 2.98 (-0.02)

Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit on Behalf of China Commercial Credit, Inc. Investors Has Been Filed in the United States District Court for the District of New Jersey -- CCCR
GlobeNewswire - Wed Aug 13, 4:43PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against China Commercial Credit, Inc. ("China Commercial" or the "Company"

(Nasdaq:CCCR) and several of its officers and directors for alleged violation of the federal securities laws during the period of November 14, 2013, through July 25, 2014 (the "Class Period"

.
CCCR: 2.98 (-0.02)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving China Commercial Credit, Inc. and a Lead Plaintiff Deadline of October 6, 2014 -- CCCR
GlobeNewswire - Tue Aug 12, 4:42PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased China Commercial Credit, Inc. ("China Commercial" or the "Company"

(Nasdaq:CCCR) common stock between November 14, 2013 and July 25, 2014.
CCCR: 2.98 (-0.02)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in China Commercial Credit, Inc. to Contact the Firm
Marketwire - Mon Aug 11, 6:07PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in China Commercial Credit, Inc. ("China Commercial" or the "Company"

(NASDAQ: CCCR) of the October 6, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against China Commercial and certain executives and directors.
CCCR: 2.98 (-0.02)

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against China Commercial Credit, Inc. -- CCCR
GlobeNewswire - Fri Aug 08, 6:30PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey, on behalf of all persons who purchased or otherwise acquired the securities of China Commercial Credit, Inc. ("China Commercial" or the "Company"

(Nasdaq:CCCR) during the period between November 14, 2013 and July 25, 2014, inclusive (the "Class Period"

. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"

.
CCCR: 2.98 (-0.02)

Cohen, Placitella & Roth, PC Investigating China Commercial Credit, Inc. for Selling Stock to Investors While Omitting to Disclose Material Financial Information in Offering Documents
PR Newswire - Thu Aug 07, 5:03PM CDT
Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased China Commercial Credit, Inc. ("CCCR" or "Company"

(NASDAQ: CCCR) stock before July 25, 2014, or in the secondary offering through a prospectus dated May 8, 2014 ("Class Period"

. The investigation concerns whether CCCR and certain of its officers and directors disseminated materially false and/or misleading information to investors in violation of Section 12(a)(2) of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, promulgated thereunder.
CCCR: 2.98 (-0.02)

EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against China Commercial Credit, Inc. -- CCCR
GlobeNewswire - Wed Aug 06, 7:00PM CDT
The Rosen Law Firm, P.A. announces that it has filed a class action lawsuit on behalf of all purchasers of China Commercial Credit, Inc. securities (Nasdaq:CCCR) between November 14, 2013 and July 25, 2014. The lawsuit is seeking to recover damages for violations of the federal securities laws.
CCCR: 2.98 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Onodrim Raises $300M to Propel EU Defence Future

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Wuliangye Aims for Global Branding Boost at Panda Event

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

KT&G Launches Heated Tobacco in Kazakhstan's Market

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...